Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans

Journal of Immunology

Volumn 163, Issue 6, 1999, Pages 3539-3548

  Hengel, Richard L ^a,b,c   Jones, Bonnie M ^a   Kennedy, M Susan ^a   Hubbard, Marjorie R ^a   McDougal, J Steven ^a,d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE SURFACE MARKER; MONOCLONAL ANTIBODY; PADGEM PROTEIN;

ANTIBIOTIC THERAPY; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE HOMING; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; STEADY STATE; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 0033568304     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123.
2. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117.
3. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582.
4. Perelson, A. S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. D. Ho. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188.
5. + cell counts, and HIV-1 production by cells. Science 271:670.
6. Pakker, N. G., D. W. Notermans, R. J. de Boer, M. T. L. Roos, F. de Wolf, A. Hill, J. M. Leonard, S. A. Danner, F. Miedema, and P. T. A. Schellekens. 1998. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat. Med. 2:208.
7. Kelleher, A. D., A. Carr, C. J. Zaunders, and D. A. Cooper. 1995. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J. Infect. Dis. 173:321.
8. + "naive" T-cells following triple-drug therapy for HIV-1 infection. AIDS Res. Hum. Retroviruses 15:435.
9. + T cells from HIV-discordant monozygotic twins. J. Exp. Med. 185:1381.
10. + T cell homeostasis and function in advanced HIV disease. Science 277:112.
11. + T-cell repertoire that are not immediately restored by antiviral or immunebased therapies. Nat. Med 3:533.
12. + repertoire during antiviral therapy. Nat. Med. 4:215.
13. - cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients. Clin. Exp. Immunol. 111:3.
14. Budd, R. C., J.-C. Cerotini, C. Horvath, C. Bron, T. Pedrazini, R. C. Howe, and H. R. MacDonald. 1987. Distinction of virgin and memory T lymphocytes: stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J. Immunol. 138:3120.
15. Sanders, M. E., M. W. Makgoba, S. O. Sharrow, D. Stephany, T. A. Springer, H. A. Young, and S. Shaw. 1988. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LAF-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-γ production. J. Immunol. 140:1401.
16. Shimuzu, Y., G. A. Van Seventer, R. Siraganian, L. Wahl, and S. Shaw. 1989. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 143:2457.
17. Jalkanen, S. T., R. F. Bargatze, and E. C. Butcher. 1986. A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur. J. Immunol 16:1195.
18. Siegelman, M. H., M. Van de Rijn, and I. L. Weissman. 1989. Mouse lymph node homing receptor cDNA clone encodes a glycoprotein revealing tandem interaction domains. Science 243:1165.
19. Aruffo, A., I. Stamenkovic, M. Melnick, C. B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303.
20. DeGrendele, H. C., P. Estess, L. J. Picker, and M. H. Siegleman. 1996. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med 183:1119.
21. Sprent, J., and D. F. Tough. 1994. Lymphocyte life-span and memory. Science 265:1395.
22. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60.
23. Picker, L. J., J. R. Treer, B. Ferguson-Darnell, P. A. Collins, D. Buck, and L. W. M. M. Terstappen. 1993. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J. Immunol. 150:1105.
24. Mackay, C. R., W. Marston, and L. Dudler. 1990. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J. Exp. Med. 171:801.
25. McDougal, J. S., A. Mawle, S. P. Cort, J. K. A. Nicholson, G. D. Cross, J. A. Scheppler-Campbell, D. Hicks, and J. Sligh. 1985. Cellular tropism of the human retrovirus HTLV-III/LAV: role of T cell activation and expression of the T4 antigen. J. Immunol. 135:3151.
26. + memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. USA 87: 6058.
27. Nicholson, J. K. A., B. M. Jones, D. F. Echenberg, T. J. Spira, and J. S. McDougal. 1987. Phenotypic distribution of T cells of patients who have subsequently developed AIDS. Clin. Immunol. Immunopathol. 43:82.
28. Nicholson, J. K. A., J. S. McDougal, T. J. Spira, G. D. Cross, B. M. Jones, and E. L. Reinherz. 1984. Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy. J. Clin. Invest. 73:191.
29. Chun, T.-W., L. Carruth, D. Finzi, X. Shen, J. A. DiGiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T. C. Quinn, et al. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183.
30. Riley, J. L., B. L. Levine, N. Craighead, T. Francomano, D. Kim, R. G. Carroll, and C. H. June. 1998. Naive and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implications for transmission and pathogenesis. J. Virol. 72:8273.
31. Borvak, J., C.-S. Chou, K. Bell, G. Van Dyke, H. Zola, O. Ramilo, and E. S. Vitetta. 1995. Expression of CD25 defines peripheral mononuclear cells with productive versus latent HIV infection. J. Immunol. 155:3196.
32. + T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI. J. Virol. 71: 4436.
33. + T lymphocytes during HIV-1 infection. Clin. Exp. Immunol. 95:436.
34. + cell levels. J. Infect. Dis. 170:775.
35. Levacher, M., F. Hulstaert, S. Tallet, S. Ullery, J. J. Pocidalo, and B. A. Bach. 1992. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin. Exp. Immunol. 90:376.
36. + T-cell determinations in persons infected with human immunodeficiency virus (HIV). Morbid. Mortal. Wkly. Rep. 46(RR-2):1.
37. Michie, C. A., A. McLean, C. Alcock, and P. C. L. Beverley. 1992. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 360:264.
38. Roederer, M., J. G. Dubs, M. T. Anderson, P. A. Raju, and L. A. Herzenberg. 1995. CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 95:2061.
39. Funaro, A., G. C. Spagnoli, C. M. Ausiello, M. Alessio, S. Roggero, D. Delia, M. Zaccolo, and F. Malavasi. 1990. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J. Immunol. 145: 2390.
40. Jackson, D. G., and J. I. Bell. 1990. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J. Immunol. 144:2811.
41. Hercend, T., J. Ritz, S. F. Schlossman, and E. L. Reinherz. 1981. Comparative expression of T9, T10, and la antigens on activated human T cell subsets. Hum. Immunol. 3:247.
42. Wang, L., J. J. Y. Chen, B. B. Gelman, R. Konig, and M. W. Cloyd. 1999. A novel mechanism of CD4 lymphocyte depletion involves effects of HIV on resting lymphocytes: induction of lymph node homing and apoptosis upon secondary signaling through homing receptors. J. Immunol. 162:268.
43. Woods, T. C., B. D. Roberts, S. T. Butera, and T. M. Folks. 1997. Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication on CD45RO memory cells. Blood 89:1635.
44. Roederer, M., P. A. Raju, D. K. Mitra, and L. A. Herzenberg. 1997. HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J. Clin. Invest. 99: 1555.
45. Spina, C. A., H. E. Prince, and D. D. Richman. 1997. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J. Clin. Invest. 99:1774.
46. Cavert, W., D. W. Notermans, K. Staskus, S. W. Wietgrefe, M. Zupancic, K. Gebhard, K. Henry, Z.-Q. Zhang, R. Mills, H. McDade, et al. 1997. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276:960.
47. + lymphocytes that includes memory cells. J. Immunol. 144:3779.
48. + lymphocytes. Proc. Natl. Acad Sci. USA 86:3301.
49. + T cell depletion and viral replication in SIV infection. Science 280:427.
50. Willerford, D. M., P. A. Hoffman, and W. M. Gallatin. 1989. Expression of lymphocyte adhesion receptors for high endothelium in primates. J. Immunol. 142:3416.
51. + T cells. J. Biol. Chem. 270:19364.
52. Groux, H., G. Torpier, D. Monté, Y. Mouton, A. Capron, and J. C. Ameisen. 1992. Activation-induced death by apoptosis in CD4 T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331.
53. lck activation and TCR desensitization independent of TCR tyrosine phosphorylation. J. Immunol. 153:2905.
54. Layne, S. P., M. J. Merges, M. Dembo, J. L. Spouge, S. R. Conley, J. P. Moore, J. L. Raina, H. Renz, H. R. Gelderblom, and P. L. Nara. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189:695
55. McDougal, J. S., S. P. Cort, M. S. Kennedy, C. D. Cabridilla, P. M. Feorino, D. P. Francis, D. Hicks, V. S. Kalyanaraman, and L. S. Martin. 1985. Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associaled virus (LAV). J. Immunol. Methods 76:171.
56. Dimitrov, D. S., R. L. Willey, H. Sato, L.-J. Chang, R. Blumenthal, and M. A. Martin. 1993. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67:2182.